Remove Communication Remove Packaging Remove Presentation
article thumbnail

Navigating Regulatory Challenges in Pharma Marketing: Best Practices

Pharma Marketing Network

Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. Develop Clear and Balanced Messaging Effective communication is at the heart of pharmaceutical marketing. Keep thorough records of approvals for future reference.

article thumbnail

Navigating Regulatory Challenges in Pharma Marketing: Best Practices

Pharma Marketing Network

Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. Develop Clear and Balanced Messaging Effective communication is at the heart of pharmaceutical marketing. Keep thorough records of approvals for future reference.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can holograms help in the frontline fight against pharmaceutical counterfeiting?

European Pharmaceutical Review

Tackling pharmaceutical counterfeiting continues, therefore, to be a clear and present priority for manufacturers, healthcare authorities and law enforcement. One area in which the problem can be tackled effectively is product packaging. Covert-hologram seals are also atracting interest within the pharmaceutical packaging sector.

Packaging 111
article thumbnail

EU antibiotic shortages being monitored by MSSG

European Pharmaceutical Review

MSSG stresses the importance of transparency in relation to shortages and highlights the need for all stakeholders to communicate in an objective and responsible way to avoid any undue public concern. In addition, MSSG supports temporary national measures such as unit dose dispensing and compounding.

article thumbnail

Mastering Responses to FDA 510(k) AI Letters: A Strategic Approach

The FDA Law Blog

We will then present an effective strategy to address FDA’s AI request in a timely manner. However, the strategy of addressing the AI request presented in the next section of this blog post applies to all three types of 510(k)s. Table 1 below shows the 510(k) submission process based on the MDUFA III Performance Goals.

FDA 75
article thumbnail

Patient Engagement in Pharma – Why and How?

Viseven

Engagement can lead to improvements in drug delivery methods, packaging designs, and support services that enhance the overall patient experience. Utilize digital tools Digital engagement tools, such as patient portals and mobile applications , can facilitate direct communication between patients and healthcare providers.

article thumbnail

CMO checklist: Selecting a partner that’s right for you?

Pharmaceutical Technology

Expectations should be clearly communicated to the service providers as early as possible. Packaging needs?. Important items to look out for in the proposal include information on what was requested in terms of batch size, number of batches expected per year, component confirmation, and the packaging plan.???.